Debt-to-equity of Moderna, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Moderna, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Moderna, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 28%, a 12% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Moderna, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 28% -4% -12% 30 Sep 2025
Q2 2025 29% -6% -18% 30 Jun 2025
Q1 2025 31% -3% -9.6% 31 Mar 2025
Q4 2024 32% -1% -3.7% 31 Dec 2024
Q3 2024 32% -1% -3.2% 30 Sep 2024
Q2 2024 36% +1% +3.8% 30 Jun 2024
Q1 2024 34% -4% -11% 31 Mar 2024
Q4 2023 33% -13% -29% 31 Dec 2023
Q3 2023 34% -22% -39% 30 Sep 2023
Q2 2023 34% -33% -49% 30 Jun 2023
Q1 2023 38% -48% -56% 31 Mar 2023
Q4 2022 46% -68% -59% 31 Dec 2022
Q3 2022 55% -91% -62% 30 Sep 2022
Q2 2022 67% -90% -57% 30 Jun 2022
Q1 2022 86% -47% -35% 31 Mar 2022
Q4 2021 114% +37% +48% 31 Dec 2021
Q3 2021 146% +107% +280% 30 Sep 2021
Q2 2021 157% +133% +542% 30 Jun 2021
Q1 2021 133% +104% +369% 31 Mar 2021
Q4 2020 77% +49% +174% 31 Dec 2020
Q3 2020 38% +12% +44% 30 Sep 2020
Q2 2020 25% 30 Jun 2020
Q1 2020 28% 31 Mar 2020
Q4 2019 28% 31 Dec 2019
Q3 2019 27% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.